Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04778709 · ClinicalTrials.gov registry record · NA
Bone Graft Particle Size on Bone Vitality and Volume
A NA study, sponsored by NYU College of Dentistry.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04778709: Clinical Trial NA study, sponsored by NYU College of Dentistry.
NCT04778709 is a NA study that was terminated before completion, run by NYU College of Dentistry. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04778709, a NA study, was terminated before completion, sponsored by NYU College of Dentistry.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
To determine the effects of small and large bone graft particles vs large particles alone on percent vital bone, percent residual graft material, measured histologically from bone biopsies of the grafted site taken at the time of dental implant placement from subjects undergoing sinus augmentation for the placement of dental implants. Dental radiographs taken post operatively will be used to estimate bone graft volume differences between conditions.
Primary Outcome
Assessment of the quality of bone that is generated in the grafted sinuses by measuring the: percent vital bone formation, percent of inflammatory tissue if any
Interventions
- DEVICE Puros allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2022-02-01 |
| Phase | NA |
Why NCT04778709 stopped before completion
NCT04778709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Puros allograft is the first listed.
NCT04778709 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04778709 about?
NCT04778709 is a clinical study titled "Bone Graft Particle Size on Bone Vitality and Volume". To determine the effects of small and large bone graft particles vs large particles alone on percent vital bone, percent residual graft material, measured histologically from bone biopsies of the grafted site taken at the time of dental implant placement from subjects undergoing sinus augmentation f...
What is the current status of trial NCT04778709?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2020-11-13. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT04778709?
The interventions under investigation include: Puros allograft (DEVICE).
Who is sponsoring clinical trial NCT04778709?
This trial is sponsored by NYU College of Dentistry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04778709's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI